1. Home
  2. OLMA vs BACQ Comparison

OLMA vs BACQ Comparison

Compare OLMA & BACQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • BACQ
  • Stock Information
  • Founded
  • OLMA 2006
  • BACQ 2024
  • Country
  • OLMA United States
  • BACQ United States
  • Employees
  • OLMA N/A
  • BACQ N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • BACQ
  • Sector
  • OLMA Health Care
  • BACQ
  • Exchange
  • OLMA Nasdaq
  • BACQ NYSE
  • Market Cap
  • OLMA 289.0M
  • BACQ 333.2M
  • IPO Year
  • OLMA 2020
  • BACQ 2024
  • Fundamental
  • Price
  • OLMA $4.42
  • BACQ $10.03
  • Analyst Decision
  • OLMA Strong Buy
  • BACQ
  • Analyst Count
  • OLMA 3
  • BACQ 0
  • Target Price
  • OLMA $27.67
  • BACQ N/A
  • AVG Volume (30 Days)
  • OLMA 1.2M
  • BACQ 211.0K
  • Earning Date
  • OLMA 05-07-2025
  • BACQ 01-01-0001
  • Dividend Yield
  • OLMA N/A
  • BACQ N/A
  • EPS Growth
  • OLMA N/A
  • BACQ N/A
  • EPS
  • OLMA N/A
  • BACQ N/A
  • Revenue
  • OLMA N/A
  • BACQ N/A
  • Revenue This Year
  • OLMA N/A
  • BACQ N/A
  • Revenue Next Year
  • OLMA N/A
  • BACQ N/A
  • P/E Ratio
  • OLMA N/A
  • BACQ $111.40
  • Revenue Growth
  • OLMA N/A
  • BACQ N/A
  • 52 Week Low
  • OLMA $2.86
  • BACQ $9.80
  • 52 Week High
  • OLMA $16.62
  • BACQ $10.07
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 60.78
  • BACQ N/A
  • Support Level
  • OLMA $2.96
  • BACQ N/A
  • Resistance Level
  • OLMA $3.41
  • BACQ N/A
  • Average True Range (ATR)
  • OLMA 0.35
  • BACQ 0.00
  • MACD
  • OLMA 0.16
  • BACQ 0.00
  • Stochastic Oscillator
  • OLMA 98.73
  • BACQ 0.00

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About BACQ BLEICHROEDER ACQUISITION CORP. I

Bleichroeder Acquisition Corp I is a blank check company.

Share on Social Networks: